We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-2.88%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$242M
AUM Growth
+$8.86M
Cap. Flow
+$14.9M
Cap. Flow %
6.16%
Top 10 Hldgs %
34.33%
Holding
60
New
15
Increased
15
Reduced
14
Closed
11

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$5.74M
2
CI icon
Cigna
CI
+$4.68M
3
NVO
Novo Nordisk
NVO
+$4.62M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$4.62M
5
MDT icon
Medtronic
MDT
+$3.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.91M
2
LLY icon
Eli Lilly
LLY
+$4.5M
3
BDX icon
Becton Dickinson
BDX
+$4.4M
4
BMY icon
Bristol-Myers Squibb
BMY
+$4.37M
5
MOH icon
Molina Healthcare
MOH
+$3.98M

Sector Composition

Rank Sector Weight
1 Healthcare 93.04%
2 Energy 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
51
Bristol-Myers Squibb
BMY
$130B
– –
-70,000
Closed -$4.37M
BPMC
52
DELISTED
Blueprint Medicines
BPMC
– –
-10,000
Closed -$1.07M
CRSP icon
53
CRISPR Therapeutics
CRSP
$5.22B
– –
-25,000
Closed -$1.9M
EW icon
54
Edwards Lifesciences
EW
$53.6B
– –
-15,068
Closed -$1.95M
HOLX
55
DELISTED
Hologic
HOLX
– –
-40,000
Closed -$3.06M
MOH icon
56
Molina Healthcare
MOH
$10.8B
– –
-12,500
Closed -$3.98M
PFE icon
57
Pfizer
PFE
$150B
– –
-100,000
Closed -$5.91M
SRPT icon
58
Sarepta Therapeutics
SRPT
$1.94B
– –
-25,000
Closed -$2.25M
WST icon
59
West Pharmaceutical
WST
$24.8B
– –
-7,500
Closed -$3.52M
MRTX
60
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-9,918
Closed -$1.46M
1 2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM

Sivik Global Healthcare's Q1 2022 Portfolio in Review

As of Q1 2022, Sivik Global Healthcare held 60 positions worth $242M, up 3.8% from $233M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Sivik Global Healthcare deployed $14.9M of net new capital in Q1 2022, opening 15 new positions and adding to 15 existing holdings. Its largest new stake was Centene: 70,000 shares worth $5.89M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 95% a quarter earlier, followed by Energy.

On the sell side, the largest reduction was Eli Lilly, an estimated $4.5M trimmed.

  • Sivik Global Healthcare's largest Q1 2022 buy was Centene: 70,000 shares worth $5.89M.
  • Sivik Global Healthcare added most to State Street SPDR S&P Biotech ETF in Q1 2022, an estimated $4.62M increase.
  • Sivik Global Healthcare's biggest Q1 2022 reduction was Eli Lilly, cutting an estimated $4.5M.
  • Sivik Global Healthcare fully exited Pfizer in Q1 2022, selling an estimated $5.91M.
  • Sivik Global Healthcare's ten largest holdings make up 34% of its $242M portfolio in Q1 2022.
  • Sivik Global Healthcare opened 15 new positions and closed 11 in Q1 2022.
  • Sivik Global Healthcare's portfolio value rose 3.8% quarter-over-quarter to $242M.

Based on Sivik Global Healthcare's 13F filing for Q1 2022, filed 9 May 2022.